In particular, the feasibility of BCR-ABL1 exosomal transcript detection in CML patients in the chronic phase, under treatment and with an undetectable level of MRD, has been reported [108]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.